NCAM1
Neural cell adhesion molecule 1
Also known as: CD56, NCAM, NCAM1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P13591
- Gene
- NCAM1
- Ensembl
- ENSG00000149294
- Chromosome
- 11
- Canonical length
- 858 aa
- Protein class
- Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters
- Subcellular location
- Plasma membrane,Cytosol
- Secretome location
- Secreted in other tissues
OverviewNCBI Gene
This gene encodes a cell adhesion protein which is a member of the immunoglobulin superfamily. The encoded protein is involved in cell-to-cell interactions as well as cell-matrix interactions during development and differentiation. The encoded protein plays a role in the development of the nervous system by regulating neurogenesis, neurite outgrowth, and cell migration. This protein is also involved in the expansion of T lymphocytes, B lymphocytes and natural killer (NK) cells which play an important role in immune surveillance. This protein plays a role in signal transduction by interacting with fibroblast growth factor receptors, N-cadherin and other components of the extracellular matrix and by triggering signalling cascades involving FYN-focal adhesion kinase (FAK), mitogen-activated protein kinase (MAPK), and phosphatidylinositol 3-kinase (PI3K). One prominent isoform of this gene, cell surface molecule CD56, plays a role in several myeloproliferative disorders such as acute myeloid leukemia and differential expression of this gene is associated with differential disease progression. For example, increased expression of CD56 is correlated with lower survival in acute myeloid leukemia patients whereas increased severity of COVID-19 is correlated with decreased abundance of CD56-expressing NK cells in peripheral blood. Alternative splicing results in multiple transcript variants encoding distinct protein isoforms. [provided by RefSeq, Aug 2020]
Canonical amino-acid sequenceUniProt
858 residues, UniProt reviewed canonical sequence.
>P13591|NCAM1
1 MLQTKDLIWT LFFLGTAVSL QVDIVPSQGE ISVGESKFFL CQVAGDAKDK DISWFSPNGE
61 KLTPNQQRIS VVWNDDSSST LTIYNANIDD AGIYKCVVTG EDGSESEATV NVKIFQKLMF
121 KNAPTPQEFR EGEDAVIVCD VVSSLPPTII WKHKGRDVIL KKDVRFIVLS NNYLQIRGIK
181 KTDEGTYRCE GRILARGEIN FKDIQVIVNV PPTIQARQNI VNATANLGQS VTLVCDAEGF
241 PEPTMSWTKD GEQIEQEEDD EKYIFSDDSS QLTIKKVDKN DEAEYICIAE NKAGEQDATI
301 HLKVFAKPKI TYVENQTAME LEEQVTLTCE ASGDPIPSIT WRTSTRNISS EEKASWTRPE
361 KQETLDGHMV VRSHARVSSL TLKSIQYTDA GEYICTASNT IGQDSQSMYL EVQYAPKLQG
421 PVAVYTWEGN QVNITCEVFA YPSATISWFR DGQLLPSSNY SNIKIYNTPS ASYLEVTPDS
481 ENDFGNYNCT AVNRIGQESL EFILVQADTP SSPSIDQVEP YSSTAQVQFD EPEATGGVPI
541 LKYKAEWRAV GEEVWHSKWY DAKEASMEGI VTIVGLKPET TYAVRLAALN GKGLGEISAA
601 SEFKTQPVQG EPSAPKLEGQ MGEDGNSIKV NLIKQDDGGS PIRHYLVRYR ALSSEWKPEI
661 RLPSGSDHVM LKSLDWNAEY EVYVVAENQQ GKSKAAHFVF RTSAQPTAIP ANGSPTSGLS
721 TGAIVGILIV IFVLLLVVVD ITCYFLNKCG LFMCIAVNLC GKAGPGAKGK DMEEGKAAFS
781 KDESKEPIVE VRTEEERTPN HDGGKHTEPN ETTPLTEPEK GPVEAKPECQ ETETKPAPAE
841 VKTVPNDATQ TKENESKALocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCAM1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 187 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 187 nTPM
- spinal cord: 145 nTPM
- heart muscle: 136 nTPM
- midbrain: 123 nTPM
- hippocampal formation: 116 nTPM
- basal ganglia: 112 nTPM
Single-cell type
- oligodendrocytes: 1,441 nCPM
- oligodendrocyte progenitor cells: 1,404 nCPM
- bergmann glia: 1,167 nCPM
- cardiomyocytes: 1,070 nCPM
- astrocytes: 955 nCPM
- adrenal medulla cells: 819 nCPM
Immune cell
- NK-cell: 54 nTPM
- gdT-cell: 3.6 nTPM
- total PBMC: 1.9 nTPM
- naive CD8 T-cell: 1.4 nTPM
- MAIT T-cell: 1.2 nTPM
- neutrophil: 0.7 nTPM
Brain region
- white matter: 728 nTPM
- hypothalamus: 522 nTPM
- basal ganglia: 494 nTPM
- pons: 460 nTPM
- cerebral cortex: 456 nTPM
- medulla oblongata: 454 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NCAM1.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 48 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- See cases
Disease | ImmuneIEDB
Conditions an epitope on NCAM1 was assayed in.
Disease | AutoantibodyPubMed
Conditions in which antibodies against NCAM1 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for NCAM1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
8 publications
- Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis.
2021 · Kidney Int · RCR 8.9 · 123 citations - The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery.
2006 · Exp Hematol · RCR 2.6 · 116 citations - Autoantibodies against NCAM1 from patients with schizophrenia cause schizophrenia-related behavior and changes in synapses in mice.
2022 · Cell Rep Med · RCR 2.5 · 32 citations - Clinicopathological phenotype and outcomes of NCAM-1+ membranous lupus nephritis.
2024 · Nephrol Dial Transplant · RCR 1.1 · 5 citations - [Autoantibody-Related Pathology in Schizophrenia].
2023 · Brain Nerve
Show 3 more
- A Case of NCAM1-Positive Lupus Nephritis with NCAM1 Antibody Titers Responsive to Rituximab.
2024 · Nephron - Long COVID is associated with female sex; Anti-NCAM1 autoantibodies are absent in patients with long COVID.
2025 · IBRO Neurosci Rep - Case Report: Anti-neural cell adhesion molecule 1 antibody-positive encephalitis presenting with schizophrenia-like symptoms and an ovarian teratoma.
2026 · Front Immunol
Reference: T cellIEDB
1 publication
- High-throughput peptide-MHC complex generation and kinetic screenings of TCRs with peptide-receptive HLA-A*02:01 molecules.
2019 · Sci Immunol · RCR 1 · 36 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.19
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.71
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell adhesion
- commissural neuron axon guidance
- epithelial to mesenchymal transition
- regulation of semaphorin-plexin signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Immunoglobulin subtype 2
- Immunoglobulin domain subtype
- Fibronectin type III
- Immunoglobulin-like domain
- Neural cell adhesion
- Immunoglobulin I-set
- Immunoglobulin-like fold
- Fibronectin type III superfamily
- Immunoglobulin-like domain superfamily
- Fibronectin type III domain
- Immunoglobulin I-set domain
- Immunoglobulin domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCAM1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCAM1 as an antibody target. Whether an autoantibody or antibody against NCAM1 could matter depends on whether native NCAM1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCAM1 is annotated at the cell surface, where native NCAM1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NCAM1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...